125 related articles for article (PubMed ID: 12578224)
1. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum.
Sidell KR; Montine KS; Picklo MJ; Olsen SJ; Amarnath V; Montine TJ
J Neuropathol Exp Neurol; 2003 Feb; 62(2):146-53. PubMed ID: 12578224
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 4-hydroxynonenal by rat Kupffer cells.
Luckey SW; Petersen DR
Arch Biochem Biophys; 2001 May; 389(1):77-83. PubMed ID: 11370675
[TBL] [Abstract][Full Text] [Related]
3. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
Di Domenico F; Tramutola A; Butterfield DA
Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.
Schaur RJ; Siems W; Bresgen N; Eckl PM
Biomolecules; 2015 Sep; 5(4):2247-337. PubMed ID: 26437435
[TBL] [Abstract][Full Text] [Related]
5. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Butterfield DA
Free Radic Biol Med; 2007 Feb; 42(3):371-84. PubMed ID: 17210450
[TBL] [Abstract][Full Text] [Related]
6. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
Sultana R; Butterfield DA
Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
[TBL] [Abstract][Full Text] [Related]
7. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
[TBL] [Abstract][Full Text] [Related]
8. Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats.
Völkel W; Alvarez-Sánchez R; Weick I; Mally A; Dekant W; Pähler A
Free Radic Biol Med; 2005 Jun; 38(11):1526-36. PubMed ID: 15890627
[TBL] [Abstract][Full Text] [Related]
9. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
10. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation.
Long EK; Murphy TC; Leiphon LJ; Watt J; Morrow JD; Milne GL; Howard JR; Picklo MJ
J Neurochem; 2008 May; 105(3):714-24. PubMed ID: 18194211
[TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
12. Are 4-hydroxy-2(E)-nonenal derived mercapturic acids and (1)H NMR metabonomics potential biomarkers of chemically induced oxidative stress in the kidney?
Mally A; Amberg A; Hard GC; Dekant W
Toxicology; 2007 Feb; 230(2-3):244-55. PubMed ID: 17184893
[TBL] [Abstract][Full Text] [Related]
13. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins.
Subramaniam R; Roediger F; Jordan B; Mattson MP; Keller JN; Waeg G; Butterfield DA
J Neurochem; 1997 Sep; 69(3):1161-9. PubMed ID: 9282939
[TBL] [Abstract][Full Text] [Related]
14. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation.
Qin Z; Hu D; Han S; Reaney SH; Di Monte DA; Fink AL
J Biol Chem; 2007 Feb; 282(8):5862-70. PubMed ID: 17189262
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
16. Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver.
Sadhukhan S; Han Y; Jin Z; Tochtrop GP; Zhang GF
Free Radic Biol Med; 2014 May; 70():78-85. PubMed ID: 24556413
[TBL] [Abstract][Full Text] [Related]
17. Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat.
Alary J; Bravais F; Cravedi JP; Debrauwer L; Rao D; Bories G
Chem Res Toxicol; 1995; 8(1):34-9. PubMed ID: 7703364
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases.
Zarkovic K; Jakovcevic A; Zarkovic N
Free Radic Biol Med; 2017 Oct; 111():110-126. PubMed ID: 27993730
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal.
Tsirulnikov K; Abuladze N; Bragin A; Faull K; Cascio D; Damoiseaux R; Schibler MJ; Pushkin A
Toxicol Appl Pharmacol; 2012 Sep; 263(3):303-14. PubMed ID: 22819785
[TBL] [Abstract][Full Text] [Related]
20. Activity of mouse liver glutathione S-transferases toward trans,trans-muconaldehyde and trans-4-hydroxy-2-nonenal.
Goon D; Saxena M; Awasthi YC; Ross D
Toxicol Appl Pharmacol; 1993 Apr; 119(2):175-80. PubMed ID: 8480327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
